Related references
Note: Only part of the references are listed.SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation
Pilar Gallego et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Relationship of the SAMe-TT2R2 Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2014)
A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin
Daniela Poli et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
Novel oral anticoagulants in non-valvular atrial fibrillation
Tatjana S. Potpara et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2013)
Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score
Stavros Apostolakis et al.
CHEST (2013)
General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
Raffaele De Caterina et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association
A. John Camm et al.
EUROPACE (2012)
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
Menno V. Huisman et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor
Alexander G. G. Turpie et al.
THROMBOSIS AND HAEMOSTASIS (2012)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
A. J. Rose et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Lars Wallentin et al.
LANCET (2010)
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Stuart J. Connolly et al.
CIRCULATION (2008)
Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review
Yi Wan et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2008)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV
Harvey D. White et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management
GP Samsa et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2000)